Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 20.6B | 17.7B | 19.0B | 21.4B |
Cost of revenue | 13.6B | 11.8B | 12.8B | 14.6B |
Gross profit | 7.0B | 5.9B | 6.2B | 6.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 2.7B | 2.5B | 2.6B | 2.9B |
Operating income | 2.2B | 1.5B | 1.7B | 2.0B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 99.5M | 104.7M | 120.4M | 155.2M |
Other income expense | — | — | — | — |
Pretax income | 2.3B | 1.5B | 1.7B | 2.0B |
Tax provision | 590.6M | 392.7M | 426.7M | 511.3M |
Net income | 1.7B | 1.1B | 1.3B | 1.5B |
Basic EPS | — | 1.7 | 1.9 | 2.4 |
Diluted EPS | — | 1.7 | 1.9 | 2.4 |
Basic average shares | — | 646.1M | 643.8M | 642.9M |
Diluted average shares | — | 646.1M | 643.8M | 642.9M |
EBITDA | 2.8B | 2.0B | 2.2B | 2.6B |
Net income from continuing op. | — | — | — | — |
Minority interests | -22.5M | -20.8M | -31.7M | -6.3M |
Preferred stock dividends | 0 | 0 | 0 | 0 |